Ticker LaunchUnderwriter
H.C. Wainwright
H.C. Wainwright appears as underwriter on 18 US IPOs and 0 SPAC IPOs tracked by Ticker Launch since 2019, leading 6 of them as lead-left (first named) bank.
US IPOs18
SPAC IPOs0
Deals by year: 2025: 1 · 2023: 1 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 2
Deals
| Company | Type | Date | Size | Role |
|---|---|---|---|---|
| Galaxy Digital Inc. | IPO | May 30, 2025 | $600.4M | Syndicate |
| U.S. GoldMining Inc. | IPO | Apr 20, 2023 | $20M | Lead-left |
| Locafy Ltd | IPO | Mar 29, 2022 | $6M | Lead-left |
| Nuvectis Pharma, Inc. | IPO | Feb 7, 2022 | — | Lead-left |
| Amylyx Pharmaceuticals, Inc. | IPO | Jan 10, 2022 | $190M | Syndicate |
| Neuphoria Therapeutics Inc. | IPO | Dec 17, 2021 | — | Syndicate |
| Janux Therapeutics, Inc. | IPO | Jun 11, 2021 | $193.8M | Syndicate |
| Barinthus Biotherapeutics plc. | IPO | Apr 30, 2021 | — | Syndicate |
| Werewolf Therapeutics, Inc. | IPO | Apr 30, 2021 | $120M | Syndicate |
| Steakholder Foods Ltd. | IPO | Mar 15, 2021 | $25M | Lead-left |
| Gold Royalty Corp. | IPO | Mar 9, 2021 | $90M | Lead-left |
| Biophytis SA | IPO | Feb 11, 2021 | $20.1M | Lead-left |
| ARS Pharmaceuticals, Inc. | IPO | Dec 4, 2020 | $241.5M | Syndicate |
| COMPASS Pathways plc | IPO | Sep 21, 2020 | $127.5M | Syndicate |
| Inventiva S.A. | IPO | Jul 13, 2020 | $107.7M | Syndicate |
| Keros Therapeutics, Inc. | IPO | Apr 8, 2020 | $96M | Syndicate |
| Genmab A/S | IPO | Jul 19, 2019 | $505.9M | Syndicate |
| Genfit S.A. | IPO | Mar 27, 2019 | $135.1M | Syndicate |
See where H.C. Wainwright ranks: US IPOs · SPAC IPOs
Track H.C. Wainwright's next deals
Subscribers get each new filing and pricing the morning after, with alerts and Excel export.